Primary Job Title Chief Executive Officer Primary Organization Vivoryon Therapeutics
Location Halle, Sachsen-Anhalt, Germany Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Ulrich Dauer joined Probiodrug as CEO on May 1, 2018. He has had a career spanning more than 20 years in the biopharmaceutical industry in both public and private companies. As one of the founders, Dr. Dauer previously worked for 14 years as CEO of 4SC AG, attracting multiple private and, upon the company’s listing at the Prime Standard segment of
Deutsche Börse in 2005, public investors. Under his leadership, 4SC closed multiple industry partnerships with international biopharmaceutical companies. In subsequent leadership positions in the biotech industry, he executed in 2014 the €130 M trade sale of Activaero and later took up CEO positions of two privately held biotech companies.Dauer holds a PhD in Chemistry from the Julius-Maximilians University of Würzburg.
